C 2 monitoring of cyclosporine in stable heart transplant patients after two daily and three daily doses

Author： Baraldo M. Francesconi A. Barbone F. Tursi V. Livi U. Furlanut M.

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.34, Iss.8, 2002-12, pp. : 3246-3248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Conversion of C-0 to C-2 monitoring of cyclosporine in stable kidney transplant patients

By Jirasiritham S. Mavichak V. Danviriyasup K. Jirasiritham S.

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 236-237

Elsevier

Access to resources Recommend Favorite

Conversion from once-daily Sandimmune cyclosporine to once-daily Neoral in renal transplant patients

By Arvind C. Vathsala A. Woo K.T.

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1681-1682

Elsevier

Access to resources Recommend Favorite

Limited utility of cyclosporine C2 monitoring in heart transplant recipients receiving ketoconazole

By Zakliczynski M. Krynicka A. Szewczyk M. Wojarski J. Zembala M.

Transplantation Proceedings, Vol. 35, Iss. 6, 2003-09 ,pp. : 2333-2334

Elsevier

Access to resources Recommend Favorite

Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction

By Cantarovich M. Quantz M. Elstein E. Ergina P. Magnan C. de Varennes B.

Transplantation Proceedings, Vol. 32, Iss. 2, 2000-03 ,pp. : 446-448

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic and pharmacodynamic correlations of cyclosporine therapy in stable renal transplant patients: evaluation of long-term target C 2

By Brunet M. Campistol J.M. Millan O. Vidal E. Esforzado N. Rojo I. Jimenez O. Oppenheimer F. Corbella J. Martorell J.

International Immunopharmacology, Vol. 3, Iss. 7, 2003-07 ,pp. : 987-999

Elsevier

Access to resources Recommend Favorite